Beovu® (Brolucizumab) for the Treatment of wet Age-related Macular Degeneration (AMD)
BEOVU (brolucizumab) is available as an intravitreal injection in a single-dose vial. Credit: Novartis.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more